Gyre Therapeutics's three largest insider shareholders as of September 29, 2026 are Songjiang Ma (President, 2.81Mn shares), Ying Luo (Chief Executive Officer, 2.57Mn shares), Weiguo Ye (Chief Operating Officer, 700.00K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Songjiang Ma | President | 0 | 2,806,084 | 2,806,084 | 45.8% | 29 May, 2025 |
| 2 | Ying Luo | Chief Executive Officer | 0 | 2,565,226 | 2,565,226 | 41.9% | 07 May, 2026 |
| 3 | Weiguo Ye | Chief Operating Officer | 700,000 | 0 | 700,000 | 11.4% | 15 Jun, 2026 |
| 4 | Group Ltd. Gni | TenPercentOwner | 0 | 40,644 | 40,644 | 0.7% | 22 Nov, 2023 |
| 5 | Thomas Wilson Eastling | Director | 15,000 | 0 | 15,000 | 0.2% | 18 Apr, 2025 |
| 6 | Nassim Usman | President Ceo | 1,636 | 0 | 1,636 | 0.0% | 01 Jul, 2024 |
| 7 | Eddie Williams | Director | 22 | 0 | 22 | 0.0% | 07 Jan, 2022 |
| 8 | Geoffrey M.D. Ling | Director | 20 | 0 | 20 | 0.0% | 07 Jan, 2022 |
| 9 | Errol B Desouza | Director | 19 | 0 | 19 | 0.0% | 05 Oct, 2021 |
| 10 | Andrea Hunt | Director | 18 | 0 | 18 | 0.0% | 07 Jan, 2022 |
| 11 | Augustine Lawlor | Director | 16 | 0 | 16 | 0.0% | 05 Oct, 2021 |
| 12 | Grant E. Blouse | Chief Scientific Officer | 6 | 0 | 6 | 0.0% | 10 Aug, 2022 |
| 13 | Seline E. Miller | Svp Finance; Interim Cfo Pao | 4 | 0 | 4 | 0.0% | 10 Aug, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 03 Aug, 2026 | Maxwell Kirkby | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 03 Aug, 2026 | Claire Weston | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | Renate Parry | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | Rodney L Nussbaum | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | Gordon Carmichael | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | Ping Zhang | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | David M. Epstein | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 10 Jun, 2026 | Dan Weng | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 09 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Acquired M | 3,000 | $0.75 | $2.25K | 703,000 | Direct |
| 09 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed S | 3,000 | $6.15 | $18.45K | 700,000 | Direct |
| 10 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Acquired M | 5,000 | $0.75 | $3.75K | 705,000 | Direct |
| 10 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed S | 5,000 | $6.24 | $31.20K | 700,000 | Direct |
| 18 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Acquired M | 3,000 | $0.75 | $2.25K | 703,000 | Direct |
| 18 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed S | 3,000 | $6.35 | $19.05K | 700,000 | Direct |
| 09 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed M | 3,000 | $0.00 | $0 | 835,701 | Direct |
| 10 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed M | 5,000 | $0.00 | $0 | 830,701 | Direct |
| 18 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed M | 3,000 | $0.00 | $0 | 827,701 | Direct |
| 11 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Acquired M | 2,800 | $0.75 | $2.10K | 702,800 | Direct |
| 11 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed S | 2,800 | $6.17 | $17.28K | 700,000 | Direct |
| 11 Jun, 2026 | Weiguo Ye | Chief Operating Officer | Disposed M | 2,800 | $0.00 | $0 | 838,701 | Direct |